For older people and frail people, the long-term benefit of medicines reduces and the potential for harm from adverse effects increases. When the benefit–risk balance changes in this way, medicine review and optimisation are important to simplify the therapeutic regimen, reduce inappropriate medicines and minimise risks. In this article, pharmacist prescriber Linda Bryant uses two case studies to illustrate important considerations during medicine reviews
Public Health Association welcomes new government’s commitment to health
Public Health Association welcomes new government’s commitment to health

The Public Health Association of New Zealand (PHA) welcomes the new government’s commitment to health as a priority for increased investment.
“The PHA congratulates Jacinda Ardern, Winston Peters and James Shaw on the creation of a coalition that will measure its success on the basis of how its policies improve people’s lives,” says PHA CEO Warren Lindberg.
“DHBs, primary care practitioners and the NGO sector urgently need relief from the financial pressures that are demoralising staff, increasing treatment errors and prolonging staff shortages.
“We are especially pleased that the new government will prioritise determinants of health, such as poverty, housing, water quality and environmental damage from climate change.
“New Zealand is internationally recognised for leadership in quality professional care, but also for its failure to ensure access to services for people who are poor, culturally and linguistically different, or otherwise disadvantaged.
“Our DHBs are struggling with avoidable hospitalisations – especially children with preventable conditions – as health promotion and prevention services have been systematically de-funded over the last decade.
“The Prime Minister’s focus on investing in wages, housing and education, and on environmental issues such as water quality and public transport, gives us all reason to hope for a healthier future.”